0	1	{'start':(0, 0), 'end':(0, 5), 'text':'Netrins and neogenin promote myotube formation'}
9	40	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 11), 'text':'During skeletal muscle development mesodermal precursor cells give rise to committed myoblasts'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(1, 12), 'end':(1, 24), 'text':'that , after proliferation and migration to appropriate sites in the embryo ,'}, {'start':(1, 25), 'end':(1, 29), 'text':'exit the cell cycle ,'}]}]}, {'start':(1, 30), 'end':(1, 34), 'text':'express muscle specific genes ,'}]}, {'start':(1, 35), 'end':(1, 42), 'text':'and fuse into multinucleated myofibers ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'This process is coordinated by a family of myogenic bHLH transcription factors'}, {'start':(2, 12), 'end':(2, 24), 'text':'that includes Myf5 , MyoD , myogenin , and MRF4 ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 11), 'text':'These factors function in concert with additional families of transcription factors ,'}, {'start':(3, 12), 'end':(3, 16), 'text':'including MEF2 and NFAT .'}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 13), 'text':'The activity of such transcription factors can be regulated by signal transduction pathways ,'}, {'start':(4, 14), 'end':(4, 22), 'text':'although the mechanisms involved are not fully understood .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 10), 'text':'Cell culture systems have proven very useful in analyzing the processes'}, {'start':(5, 11), 'end':(5, 18), 'text':'by which myoblasts differentiate into multinucleated myotubes .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 6), 'text':'Differentiation of myoblast cell lines is induced'}, {'start':(6, 7), 'end':(6, 19), 'text':'by transferring confluent cultures into mitogen deficient differentiation medium ( DM ) ,'}]}, {'start':(6, 20), 'end':(6, 28), 'text':'after which they induce the differentiation factor myogenin ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 29), 'end':(6, 34), 'text':'withdraw from the cell cycle ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 35), 'end':(6, 38), 'text':'elongate and align ,'}, {'start':(6, 39), 'end':(6, 48), 'text':'express muscle specific proteins , and fuse ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 10), 'text':'Several signaling pathways have been implicated in promoting myogenic differentiation ;'}, {'start':(7, 11), 'end':(7, 12), 'text':'however ,'}]}, {'start':(7, 13), 'end':(7, 27), 'text':'because the most commonly used stimulus for in vitro differentiation is removal of serum ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 28), 'end':(7, 32), 'text':'the extracellular factors and receptors'}, {'start':(7, 33), 'end':(7, 42), 'text':'that initiate these pathways during myogenesis are largely unknown .'}]}]}, {'start':(8, 0), 'end':(8, 15), 'text':'Differentiation of cells in the skeletal muscle lineage is also positively regulated by cell-cell contact .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 32), 'text':'We have been studying this process with particular emphasis on the role of CDO , an orphan receptor of the Ig and fibronectin type III ( FNIII ) repeat family ( ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 12), 'text':'CDO is expressed at high levels in the myogenic compartment during embryogenesis ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 13), 'end':(10, 20), 'text':'and mice lacking CDO via targeted mutagenesis display'}, {'start':(10, 21), 'end':(10, 24), 'text':'delayed muscle development .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 6), 'text':'CDO also promotes myogenesis in vitro ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 7), 'end':(11, 11), 'text':'signaling through a yet-to-be-identified pathway'}, {'start':(11, 12), 'end':(11, 26), 'text':'to posttranslationally activate MyoD family members through increased heterodimerization with their E protein partners .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 8), 'text':'CDO is a component of a cell surface complex'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 9), 'end':(12, 14), 'text':'found at sites of cell-cell contact'}, {'start':(12, 15), 'end':(12, 35), 'text':'that also includes the related Ig and FNIII protein BOC and the promyogenic cell adhesion molecules , N- and M-cadherin .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(13, 0), 'end':(13, 2), 'text':'We have proposed'}, {'start':(13, 3), 'end':(13, 17), 'text':'that this complex mediates some of the positive effects of cell-cell contact on myogenesis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 4), 'text':'Netrins comprise a small family'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 5), 'end':(14, 10), 'text':'of secreted proteins related to laminins'}, {'start':(14, 11), 'end':(14, 18), 'text':'that associate with cell membranes and ECM .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(15, 0), 'end':(15, 1), 'text':'Netrins function'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 2), 'end':(15, 15), 'text':'as evolutionarily conserved axon guidance cues able to trigger both attractive and repulsive responses'}, {'start':(15, 16), 'end':(15, 24), 'text':'mediated via two classes of cell surface receptors .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 14), 'text':'The first class belongs , like CDO , to the Ig and FNIII repeat family'}, {'start':(16, 15), 'end':(16, 20), 'text':'and includes DCC and neogenin ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 21), 'end':(16, 23), 'text':'the second class'}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 24), 'end':(16, 28), 'text':'contain Ig and thrombospondin repeats'}, {'start':(16, 29), 'end':(16, 36), 'text':'and includes the UNC-5H proteins ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 7), 'text':'DCC receptors mediate attractive responses to netrins ,'}, {'start':(17, 8), 'end':(17, 18), 'text':'whereas complexes of DCC and UNC-5 mediate repulsion ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 15), 'text':'Functions for netrins and netrin receptors outside the nervous system have received much less attention .'}, {'start':(19, 0), 'end':(19, 13), 'text':'Several observations make netrins and their receptors interesting candidates as regulators of myogenesis .'}]}]}, {'start':(20, 0), 'end':(20, 27), 'text':'First , mRNAs for netrin-1 , netrin-3 , and neogenin are expressed in somites and developing skeletal muscle between E10 .5 and E14 .5 during murine embryogenesis .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 5), 'text':'Second , netrin-1 signals in neurons'}, {'start':(21, 6), 'end':(21, 10), 'text':'to activate several pathways also'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 11), 'end':(21, 15), 'text':'implicated in promoting myogenesis ,'}, {'start':(21, 16), 'end':(21, 31), 'text':'including the calcineurin , p38 and p42 and 44 MAPK , and phosphatidylinositol 3-kinase pathways .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 31), 'text':'Third , guidance of axons by extracellular cues requires localized alterations in the actin cytoskeleton of growth cones , and DCC can signal to modulate the activity of specific Rho GTPases ,'}, {'start':(22, 32), 'end':(22, 39), 'text':'known regulators of actin dynamics ( ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(23, 0), 'end':(23, 3), 'text':'It seems highly likely'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 4), 'end':(23, 12), 'text':'that the elongation , alignment , and fusion steps'}, {'start':(23, 13), 'end':(23, 26), 'text':'that occur during myotube formation also require alterations of the cytoskeleton ( ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 24), 'text':'Finally , netrin-1 and neogenin function in an adhesive , rather than a guidance , role during mammary gland morphogenesis ( ) , an activity'}, {'start':(24, 25), 'end':(24, 35), 'text':'that could contribute to the promyogenic effects of cell-cell contact .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 12), 'text':'Interestingly , neogenin morphant zebrafish were recently reported to display defects in somitogenesis'}, {'start':(25, 13), 'end':(25, 17), 'text':'( before muscle development )'}]}, {'start':(25, 18), 'end':(25, 32), 'text':'that are consistent with a potential role for neogenin in convergent extension ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 2), 'text':'We report here'}, {'start':(26, 3), 'end':(26, 10), 'text':'that cultured myoblasts express neogenin and netrin-3 .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(27, 0), 'end':(27, 14), 'text':'Up- or down modulation of neogenin levels increases or decreases myotube formation , respectively ,'}, {'start':(27, 15), 'end':(27, 29), 'text':'and neogenin can enhance the activity of myogenic bHLH- and NFAT dependent reporter constructs .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 17), 'text':'Treatment of myoblasts with recombinant netrin promotes myotube formation and NFAT activation in a neogenin dependent manner .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 8), 'text':'Finally , neogenin and CDO form a complex ,'}, {'start':(29, 9), 'end':(29, 14), 'text':'and CDO modulates netrin signaling .'}]}]}]}]}]}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(30, 0), 'end':(30, 2), 'text':'These results suggest'}, {'start':(30, 3), 'end':(30, 29), 'text':'that netrin-3 and neogenin promote myogenic differentiation by an autocrine mechanism , possibly as components of a higher order complex of several promyogenic cell surface proteins .'}]}]}
1	9	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 10), 'text':'Differentiation of skeletal myoblasts into multinucleated myotubes is a multistep process'}, {'start':(0, 11), 'end':(0, 18), 'text':'orchestrated by several families of transcription factors ,'}]}, {'start':(0, 19), 'end':(0, 25), 'text':'including myogenic bHLH and NFAT proteins .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(1, 0), 'end':(1, 15), 'text':'The activities of these factors and formation of myotubes are regulated by signal transduction pathways ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 16), 'end':(1, 19), 'text':'but few extracellular factors'}, {'start':(1, 20), 'end':(1, 28), 'text':'that might initiate such signals have been identified .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 6), 'text':'One exception is a cell surface complex'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 7), 'end':(2, 11), 'text':'containing promyogenic Ig superfamily members'}, {'start':(2, 12), 'end':(2, 19), 'text':'( CDO and BOC ) and cadherins .'}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 10), 'text':'Netrins and their receptors are established regulators of axon guidance ,'}, {'start':(3, 11), 'end':(3, 22), 'text':'but little is known of their function outside the nervous system .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 2), 'text':'We report here'}, {'start':(4, 3), 'end':(4, 15), 'text':'that myoblasts express the secreted factor netrin-3 and its receptor , neogenin .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 4), 'text':'These proteins stimulate myotube formation'}, {'start':(5, 5), 'end':(5, 13), 'text':'and enhance myogenic bHLH- and NFAT dependent transcription .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 10), 'text':'Furthermore , neogenin binds to CDO in a cis fashion ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 11), 'end':(6, 12), 'text':'and myoblasts'}, {'start':(6, 13), 'end':(6, 22), 'text':'lacking CDO are defective in responding to recombinant netrin .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(7, 0), 'end':(7, 2), 'text':'It is proposed'}, {'start':(7, 3), 'end':(7, 28), 'text':'that netrin-3 and neogenin may promote myogenic differentiation by an autocrine mechanism as components of a higher order complex of several promyogenic cell surface proteins .'}]}]}]}
194	244	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'Cell culture'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 10), 'text':'C2C12 , F3 , and 10T1 and 2 cells were cultured'}, {'start':(2, 11), 'end':(2, 14), 'text':'as described previously .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 7), 'text':'Differentiation of C2C12 and F3 cells was induced'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 8), 'end':(3, 33), 'text':'by switching cultures from DME and 15 % FBS to either DME and 2 % horse serum ( DM ) or DME and 5 % FBS'}, {'start':(3, 34), 'end':(3, 36), 'text':'as indicated .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 14), 'text':'All quantified myotube formation assays were performed at least four times with similar results .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 12), 'text':'COS and 293T cells were cultured in DME and 10 % FBS .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 12), 'text':'Primary myoblasts were obtained from the hind limbs of wild-type and Cdo -'}, {'start':(6, 13), 'end':(6, 27), 'text':'/ - mice ( ) at postpartum day 21 by the methods of and .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 13), 'text':'In brief , muscle tissue was collected , connective tissue and fat removed ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 14), 'end':(7, 17), 'text':'and muscles dissociated mechanically'}, {'start':(7, 18), 'end':(7, 20), 'text':'and enzymatically .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 36), 'text':'Cells were plated on tissue-culture plastic in Ham \'s F10 medium with 20 % FBS , 10 ng and ml hepatocyte growth factor , 5 mg and ml heparin , and 2.5 ng and ml bFGF .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 7), 'text':'Floating cells were collected 24 h later ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 8), 'end':(9, 12), 'text':'inoculated on collagen coated plates'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 13), 'end':(9, 18), 'text':'and cultured in the same medium'}, {'start':(9, 19), 'end':(9, 23), 'text':'without hepatocyte growth factor .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 6), 'text':'Several rounds of selective adhesion were performed'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(10, 7), 'end':(10, 13), 'text':'until a pure population of myoblasts ('}, {'start':(10, 14), 'end':(10, 23), 'text':'as assessed by immunocytochemistry for MyoD ) was obtained .'}]}]}, {'start':(11, 0), 'end':(11, 25), 'text':'Cultures were treated with recombinant chicken netrin-2 ( R & D Systems ; 25 ng and ml ) in fresh DME and 5 % FBS .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 8), 'text':'Stable expression of , and RNAi against , neogenin'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 1), 'text':'A cDNA'}, {'start':(13, 2), 'end':(13, 12), 'text':'comprising a complete human neogenin ORF was provided by E. Fearon'}]}, {'start':(13, 13), 'end':(13, 22), 'text':'( University of Michigan , Ann Arbor , MI )'}]}, {'start':(13, 23), 'end':(13, 31), 'text':'and inserted into the expression vector , pBabePuro .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 9), 'text':'C2C12 cells were transfected with this vector or a vector'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 10), 'end':(14, 17), 'text':'lacking a cDNA insert with the FuGene6 reagent'}, {'start':(14, 18), 'end':(14, 23), 'text':'( Roche ) , and puromycin'}]}, {'start':(14, 24), 'end':(14, 31), 'text':'resistant colonies selected and pooled for analysis .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 12), 'text':'For RNAi studies , three sequences against mouse neogenin were tested initially .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 0), 'text':'Oligonucleotides'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 1), 'end':(16, 12), 'text':'corresponding to the neogenin sequences were cloned into the pSilencer 2.0-U6 vector'}, {'start':(16, 13), 'end':(16, 16), 'text':'( Ambion ) ,'}]}, {'start':(16, 17), 'end':(16, 48), 'text':'and 9.0 mug of the individual vectors or parental vector were transfected with 1.0 mug of an EGFP expression vector ( CLONTECH Laboratories , Inc. ) into C2C12 cells with FuGene6 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 24), 'text':'GFP positive cells were isolated 24 h later , with a FACDiVa flow cytometer ( Becton Dickinson ) and identical numbers of cells replated .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 6), 'text':'The cultures were harvested 48 h later'}, {'start':(18, 7), 'end':(18, 15), 'text':'and analyzed for neogenin expression by Western blotting .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 8), 'text':'The most effective sequence was chosen for further use'}, {'start':(19, 9), 'end':(19, 25), 'text':'and corresponds to nucleotides 3180-3198 of the GenBank sequence of murine neogenin ( GenBank/EMBL/DDBJ accession no .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 1), 'text':'NM_008684 :'}, {'start':(20, 2), 'end':(20, 4), 'text':'ACCTAGAACCATCATAGTG ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 11), 'text':'To test the effects of RNAi to neogenin on myotube formation ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 12), 'end':(21, 41), 'text':'10-cm plates of C2C12 cells were cotransfected with 9.5 mug of control or neogenin RNAi vector with 0.5 mug of pQ-lacZ , a vector driving expression of nuclear localized beta-gal'}, {'start':(21, 42), 'end':(21, 54), 'text':'( provided by D. Sassoon , Mount Sinai School of Medicine ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 14), 'text':'48 h after transfection , the cultures were transferred to DME plus 5 % FBS'}, {'start':(22, 15), 'end':(22, 18), 'text':'to stimulate differentiation ;'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(22, 19), 'end':(22, 35), 'text':'24 h later the cells were fixed with 4 % PFA , permeabilized with 0.01 % NP-40'}, {'start':(22, 36), 'end':(22, 43), 'text':'and stained for beta-gal activity with X-gal .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 7), 'text':'The cultures were subsequently immunostained for MHC expression'}, {'start':(23, 8), 'end':(23, 13), 'text':'as described previously ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 26), 'text':'For rescue experiments , the transfections included 4.5 mug control or neogenin RNAi vector , 4.5 mug pBabePuro or pBabePuro-hNeogenin vector , and 0.5 mug pQ-lacZ ;'}, {'start':(24, 27), 'end':(24, 34), 'text':'the remainder of the protocol was identical .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 3), 'text':'Protein and RNA analysis'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 4), 'text':'Western blot analyses were performed'}, {'start':(26, 5), 'end':(26, 8), 'text':'as described in .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 60), 'text':'Antibodies used were antineogenin ( Santa Cruz Biotechnology , Inc. ) ; antinetrin-3 ( provided by H. Cooper , Walter and Eliza Hall Institute , Victoria , Australia ; ) ; anti-DCC ( Santa Cruz Biotechnology , Inc. ) ; anti-NFATc3 ( Santa Cruz Biotechnology , Inc. ) ; anti-CDO ( Zymed Laboratories ) ; antipan cadherin ( Sigma-Aldrich ) ;'}, {'start':(27, 61), 'end':(27, 90), 'text':'anti-MHC ( MF20 ; Developmental Studies Hybridoma Bank ) ; anti-MyoD ( Santa Cruz Biotechnology , Inc. ) ; antimyogenin ( F5D ; Santa Cruz Biotechnology , Inc. ) ;'}]}, {'start':(27, 91), 'end':(27, 96), 'text':'and anti-TnT ( Sigma-Aldrich ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 7), 'text':'To study neogenin and CDO complex formation ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(28, 8), 'end':(28, 11), 'text':'co-immunoprecipitation techniques were performed'}, {'start':(28, 12), 'end':(28, 17), 'text':'as described previously ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 2), 'text':'CDO deletion mutants'}, {'label':'joint', 'direction':'None', 'children':[{'start':(29, 3), 'end':(29, 18), 'text':'lacking each individual ectodomain repeat were constructed by a combination of PCR and conventional cloning techniques'}, {'start':(29, 19), 'end':(29, 24), 'text':'and verified by sequence analysis .'}]}]}, {'start':(30, 0), 'end':(30, 11), 'text':'The CDO ( TMintra ) mutant was previously described ( ) .'}]}, {'start':(31, 0), 'end':(31, 11), 'text':'Details on the construction of these mutants are available on request .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 13), 'text':'Total cellular RNA was isolated with the TRIzol reagent ( Life Technologies ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 7), 'text':'Northern blot analyses with 32 P labeled probes'}, {'start':(33, 8), 'end':(33, 9), 'text':'were performed'}]}, {'start':(33, 10), 'end':(33, 15), 'text':'as described previously ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 11), 'text':'Mouse netrin-1 and netrin-3 cDNA probes were derived from mouse EST clones'}, {'start':(34, 12), 'end':(34, 16), 'text':'obtained from Open Biosystems .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 1), 'text':'Luciferase assays'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 5), 'text':'C2C12 and 10T1 and 2 cells'}, {'start':(36, 6), 'end':(36, 20), 'text':'cultured in 6-well plates were cotransfected with 4Rtk-luc or NFAT-luc reporters ( 500 ng ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 21), 'end':(36, 64), 'text':'provided by A. Lassar , Harvard University , Cambridge , MA , and G. Crabtree , Stanford University , Stanford , CA , respectively ) , pBabePuro or pBabePuro-neogenin ( 500 ng ) , and pCMV-lacZ as an internal control ( 50 ng )'}, {'start':(36, 65), 'end':(36, 67), 'text':'using FuGene6 .'}]}]}]}]}]}]}]}, {'start':(37, 0), 'end':(37, 24), 'text':'In the case of 4Rtk-luc assays in 10T1 and 2 cells , 5 ng each of MyoD and E12 expression vectors were also included .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 10), 'text':'48 h after transfection , cells were harvested and luciferase activity'}, {'start':(38, 11), 'end':(38, 19), 'text':'assessed with the Promega luciferase assay system kit .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(39, 0), 'end':(39, 0), 'text':'Microscopy'}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 5), 'text':'Cultures were processed for MHC expression'}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 6), 'end':(40, 13), 'text':'and and or beta-gal activity as described above'}, {'start':(40, 14), 'end':(40, 47), 'text':'and examined on a phase contrast microscope ( model Eclipse TS100 ; Nikon ) with Plan Fluor 10x and 0 .3 and 20x and 0 .45 objectives ( Nikon ) , at RT. .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 12), 'text':'Images were captured with a Spot RT Color camera ( model 2.2.1 )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 13), 'end':(41, 15), 'text':'using Spot software'}, {'start':(41, 16), 'end':(41, 24), 'text':'( version 3.5.9 ) and Adobe Photoshop 7.0 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 2), 'text':'Online supplemental material'}, {'start':(43, 0), 'end':(43, 1), 'text':'Fig .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 13), 'text':'S1 shows growth curves of C2C12 and puro and C2C12 and neogenin cells .'}, {'start':(45, 0), 'end':(45, 1), 'text':'Fig .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 1), 'text':'S2 shows'}, {'start':(46, 2), 'end':(46, 14), 'text':'that expression of neogenin RNAi reduces myotube formation in GFP sorted cells .'}]}, {'start':(47, 0), 'end':(47, 1), 'text':'Fig .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 6), 'text':'S3 shows growth curves of C2C12 cells'}, {'start':(48, 7), 'end':(48, 16), 'text':'treated with 5 % FBS plus or minus netrin-2 .'}]}, {'start':(49, 0), 'end':(49, 7), 'text':'Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200405039/DC1 .'}]}]}]}]}
146	194	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'start':(1, 0), 'end':(1, 18), 'text':'Skeletal myogenesis is widely studied as a model system for the study of lineage specification and cell differentiation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 11), 'text':'One reason for this is the tractability of myoblast cell lines ,'}, {'start':(2, 12), 'end':(2, 28), 'text':'which are easily induced to differentiate into myotubes by removal of serum from the culture medium .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 3), 'text':'Consistent with serum deprivation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 4), 'end':(3, 9), 'text':'promoting myogenic differentiation is the observation'}, {'start':(3, 10), 'end':(3, 23), 'text':'that many commonly studied growth factors are antagonistic to this process ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 12), 'text':'However , the positive regulation of myogenesis by signal transduction pathways strongly suggests'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 13), 'end':(4, 21), 'text':'that myoblast differentiation is promoted by extracellular signaling ligands'}, {'start':(4, 22), 'end':(4, 27), 'text':'working via cell surface receptors .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 8), 'text':'Although a few such factors have been identified ,'}, {'start':(5, 9), 'end':(5, 18), 'text':'including IGF1 , prostaglandin F 2alpha , and interleukin-4 ,'}]}, {'start':(5, 19), 'end':(5, 39), 'text':'the small number currently known is striking by comparison with the advanced state of knowledge on transcriptional regulation of differentiation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 8), 'text':'Here , it is demonstrated for the first time'}, {'start':(6, 9), 'end':(6, 23), 'text':'that netrins and the netrin receptor , neogenin , promote myotube formation in vitro .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 18), 'text':'Furthermore , this is one of the only reports of a function for netrins outside the nervous system ,'}, {'start':(7, 19), 'end':(7, 25), 'text':'broadening their potential roles in morphogenesis .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 5), 'text':'Netrins and neogenin promote myotube formation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 14), 'text':'Several lines of evidence indicate that netrin-neogenin signaling promotes specific aspects of myoblast differentiation :'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 15), 'end':(9, 26), 'text':'myoblast cell lines and primary myoblasts express both netrin-3 and neogenin ;'}, {'start':(9, 27), 'end':(9, 50), 'text':'( b ) overexpression of neogenin enhanced myotube formation by C2C12 cells , whereas RNAi mediated " knockdown " of neogenin inhibited it ;'}]}, {'start':(9, 51), 'end':(9, 65), 'text':'( c ) exogenous chicken netrin-2 enhanced myotube formation in a neogenin dependent fashion ;'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 66), 'end':(9, 78), 'text':'neogenin increased the activity of myogenic bHLH factor- and NFAT dependent reporters ;'}, {'start':(9, 79), 'end':(9, 101), 'text':'and ( e ) netrin-2 treatment increased the levels of the activated form of NFATc3 , again in a neogenin dependent fashion .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 4), 'text':'Taking these results together ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(10, 5), 'end':(10, 6), 'text':'we propose'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 7), 'end':(10, 15), 'text':'that netrin-3 and neogenin function in an autocrine loop'}, {'start':(10, 16), 'end':(10, 20), 'text':'to stimulate myotube formation .'}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 7), 'text':'Although exogenously supplied chicken netrin-2 and both endogenous'}, {'start':(11, 8), 'end':(11, 16), 'text':'and exogenously expressed neogenin clearly stimulated myotube formation ,'}]}, {'start':(11, 17), 'end':(11, 28), 'text':'certain aspects of this putative autocrine loop remain to be established .'}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 5), 'text':'First , the level of neogenin'}, {'start':(12, 6), 'end':(12, 15), 'text':'produced by C2C12 cells did not change during differentiation ,'}]}, {'start':(12, 16), 'end':(12, 17), 'text':'and ,'}]}, {'start':(12, 18), 'end':(12, 24), 'text':'whereas netrin-3 did increase in DM ,'}]}, {'start':(12, 25), 'end':(12, 33), 'text':'it was also produced by cells in GM .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 17), 'text':'Thus , something in addition to the amounts of these proteins may keep their signaling activities in check'}, {'start':(13, 18), 'end':(13, 24), 'text':'when the cells are in GM .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 6), 'text':'Because netrins are not freely soluble ,'}, {'start':(14, 7), 'end':(14, 47), 'text':'but rather are associated with cell membranes and ECM , one possibility is that netrin-3 on the surface of one cell and neogenin on the surface of another may only encounter each other as a consequence of close cell-cell proximity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 5), 'text':'Consistent with this possibility , netrin-3'}, {'start':(15, 6), 'end':(15, 21), 'text':'produced by C2C12 cells was not detected in cell culture supernatants ( unpublished data ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 6), 'text':'Cell-cell contact is a promyogenic condition ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 7), 'end':(16, 14), 'text':'and netrin-neogenin interactions may contribute to this phenomenon'}, {'start':(16, 15), 'end':(16, 22), 'text':'( see next sub-section of Discussion ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(17, 0), 'end':(17, 5), 'text':'Second , it should be noted'}, {'start':(17, 6), 'end':(17, 23), 'text':'that our evidence for netrin function in myoblasts relies on the use of exogenously provided chicken netrin-2 ,'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(17, 24), 'end':(17, 30), 'text':'and it has not yet been possible'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 31), 'end':(17, 34), 'text':'to generate direct evidence'}, {'start':(17, 35), 'end':(17, 40), 'text':'that endogenous netrin-3 works identically .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 20), 'text':'Unfortunately , none of several different netrin-3 RNAi sequences resulted in reduction of netrin-3 protein levels ( unpublished data ) ,'}, {'start':(18, 21), 'end':(18, 29), 'text':'and neutralizing antibodies to netrin-3 are not available .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 11), 'text':'However , netrin-2 required neogenin for its effects on C2C12 cells ;'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 12), 'end':(19, 18), 'text':'netrin-3 fusion proteins bind to neogenin ;'}, {'start':(19, 19), 'end':(19, 30), 'text':'and endogenous netrin-3 co-immunoprecipitated with endogenous neogenin in C2C12 cell extracts .'}]}]}]}]}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 14), 'text':'Therefore , it seems likely that netrin-3 is a functional neogenin ligand in myoblasts ,'}, {'start':(20, 15), 'end':(20, 24), 'text':'particularly as these cells did not express detectable netrin-1 .'}]}]}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(21, 0), 'end':(21, 10), 'text':'Another interesting aspect of netrin-2 and neogenin activity in myoblasts was'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(21, 11), 'end':(21, 16), 'text':'that these factors stimulated myotube formation'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 17), 'end':(21, 28), 'text':'without significantly altering the level of several muscle specific gene products ,'}, {'start':(21, 29), 'end':(21, 36), 'text':'including MyoD , myogenin , and MHC .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(22, 0), 'end':(22, 22), 'text':'In contrast , the levels of another muscle specific protein , TnT , were increased by treatment of C2C12 cells with netrin-2 ,'}, {'start':(22, 23), 'end':(22, 34), 'text':'and induction of TnT was accelerated in C2C12 and neogenin cells .'}]}, {'start':(23, 0), 'end':(23, 14), 'text':'It is possible that TnT represents a specific target of netrin and neogenin signaling .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 6), 'text':'Consistent with this possibility are the observations'}, {'start':(24, 7), 'end':(24, 20), 'text':'that neogenin enhanced myogenic bHLH factor- and NFAT dependent transcription in reporter assays ,'}]}, {'start':(24, 21), 'end':(24, 33), 'text':'and netrin-2 treatment led to production of the activated form of NFATc3 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(25, 0), 'end':(25, 4), 'text':'Alternatively , it is possible'}, {'label':'joint', 'direction':'None', 'children':[{'start':(25, 5), 'end':(25, 17), 'text':'that TnT expression is maximized within the cellular environment of the myotube ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 18), 'end':(25, 25), 'text':'and that the elevated levels of this protein'}, {'start':(25, 26), 'end':(25, 37), 'text':'seen in netrin-2-treated cells occur secondarily to enhancement of myotube formation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 2), 'text':'It may be'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(26, 3), 'end':(26, 4), 'text':'that ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 5), 'end':(26, 19), 'text':'while transcriptional regulation plays a role in netrin-neogenin-mediated myotube formation , the most important pathways'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 20), 'end':(26, 27), 'text':'involved in this process are similar to those'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(26, 28), 'end':(26, 33), 'text':'used by these families of molecules'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 34), 'end':(26, 37), 'text':'to alter the cytoskeleton'}, {'start':(26, 38), 'end':(26, 46), 'text':'in migrating and turning growth cones ( ) .'}]}]}]}]}]}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 24), 'text':'Dynamic changes in cytoskeletal architecture are highly likely to be necessary for the elongation , alignment , adhesion and fusion steps of myotube formation ;'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(27, 25), 'end':(27, 37), 'text':'although these processes occur simultaneously with induction of muscle specific gene expression ,'}, {'start':(27, 38), 'end':(27, 47), 'text':'they may not be strictly dependent on transcriptional regulation .'}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 7), 'text':'The established ability of netrins and their receptors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 8), 'end':(28, 27), 'text':'to signal locally at the tips of axonal growth cones makes them appealing candidates as regulators of the morphological changes'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 28), 'end':(28, 38), 'text':'that occur during formation of myotubes , independent of their ability'}, {'start':(28, 39), 'end':(28, 42), 'text':'to stimulate transcription .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(29, 0), 'end':(29, 8), 'text':'Cell surface receptor complexes and regulation of myogenic differentiation'}, {'label':'joint', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 7), 'text':'It has long been appreciated that cell-cell contact'}, {'start':(30, 8), 'end':(30, 17), 'text':'and and or high cell density positively regulates myogenesis .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 30), 'text':'This is apparent in disparate phenomena , such as the community effect in determination of the muscle lineage and the need for aggregation for differentiation of certain myogenic cell lines .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 7), 'text':'We have been studying a cell surface complex'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 8), 'end':(32, 13), 'text':'found at sites of cell-cell contact'}, {'start':(32, 14), 'end':(32, 20), 'text':'which is depicted as a model in'}]}]}, {'start':(32, 21), 'end':(32, 24), 'text':'and that includes :'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 25), 'end':(32, 34), 'text':'the related Ig and FNIII proteins CDO and BOC ;'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 35), 'end':(32, 51), 'text':'and ( b ) the promyogenic cell adhesion molecules , N- and M-cadherin , and the cadherin'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 52), 'end':(32, 56), 'text':'associated proteins beta- and alpha-catenin'}, {'start':(32, 57), 'end':(32, 59), 'text':'( , ;'}]}]}, {'start':(32, 60), 'end':(32, 66), 'text':'and unpublished data for alpha-catenin ) .'}]}]}]}, {'start':(33, 0), 'end':(33, 11), 'text':'This complex is well situated to coordinate multiple aspects of myogenesis .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 27), 'text':'CDO signals to posttranslationally activate MyoD family members through increased heterodimerization with E proteins , most likely via CDO directed phosphorylation of E12 and E47 ( ) .'}, {'start':(35, 0), 'end':(35, 23), 'text':'Cadherins mediate cell-cell adhesion via tethering to the actin cytoskeleton and signal to increase the activity of the promyogenic small GTPase , RhoA .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'This work demonstrated'}, {'start':(36, 3), 'end':(36, 13), 'text':'that neogenin also binds to CDO in a cis fashion .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 4), 'text':'Furthermore , netrin-3 and cadherins'}, {'start':(37, 5), 'end':(37, 8), 'text':'co-immunoprecipitated with neogenin .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'manner-means', 'direction':'RightToLeft', 'children':[{'start':(38, 0), 'end':(38, 8), 'text':'By analogy with netrin-1 and DCC ( ) ,'}, {'start':(38, 9), 'end':(38, 18), 'text':'it seems likely that netrin-3 binds directly to neogenin ;'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 19), 'end':(38, 38), 'text':'however , the neogenin-cadherin interaction might occur directly or indirectly via neogenin binding to CDO and and or BOC ,'}, {'start':(38, 39), 'end':(38, 46), 'text':'which may provide direct association with cadherins .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 23), 'text':'The formation of such a receptor complex or complexes in myoblasts resembles an emerging picture of axon guidance receptor complexes in growth cones .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 10), 'text':'DCC and UNC -40 family proteins ( which include neogenin )'}, {'start':(40, 11), 'end':(40, 25), 'text':'interact in cis with netrin receptors of the UNC5 family ; with Robo proteins ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 26), 'end':(40, 31), 'text':'which are Ig and FNIII domain'}, {'start':(40, 32), 'end':(40, 40), 'text':'containing receptors for the Slit family of ligands ;'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 41), 'end':(40, 47), 'text':'and with an Ig and FNIII domain'}, {'start':(40, 48), 'end':(40, 52), 'text':'containing receptor tyrosine phosphatase .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 14), 'text':'Robo receptors , in turn , can form cis complexes with N-cadherin ( ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 13), 'text':'The dynamics of neither the axon guidance receptor complexes nor the complexes in myoblasts'}, {'start':(42, 14), 'end':(42, 21), 'text':'that we have described are well understood .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(43, 0), 'end':(43, 21), 'text':'Purification and analysis of native complexes will be required to address how many transmembrane components can be part of a single complex'}, {'start':(43, 22), 'end':(43, 29), 'text':'and whether some interactions are mutually exclusive .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 26), 'text':'However , a key aspect of the myoblast model is that the components of the complex or complexes display interdependence in some of their promyogenic activities .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 2), 'text':'Examples include :'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 3), 'end':(45, 10), 'text':'CDO must be capable of binding to cadherins'}, {'start':(45, 11), 'end':(45, 17), 'text':'to stimulate differentiation of C2C12 cells ;'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(45, 18), 'end':(45, 25), 'text':'( b ) BOC is dependent on CDO'}, {'start':(45, 26), 'end':(45, 32), 'text':'to promote differentiation of C2C12 cells ;'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 33), 'end':(45, 37), 'text':'and ( c ) netrin-3'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 38), 'end':(45, 39), 'text':'( assuming'}, {'start':(45, 40), 'end':(45, 45), 'text':'it acts similarly to netrin-2 )'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(45, 46), 'end':(45, 57), 'text':'requires not only its receptor , neogenin , but also CDO ,'}, {'start':(45, 58), 'end':(45, 62), 'text':'to stimulate myotube formation .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(46, 0), 'end':(46, 10), 'text':'Assembly of a multiprotein complex localized at sites of cell-cell contact'}, {'start':(46, 11), 'end':(46, 22), 'text':'and containing multiple signaling and adhesive components is an appealing notion ,'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 23), 'end':(46, 30), 'text':'as such complexes could permit diverse signaling events'}, {'start':(46, 31), 'end':(46, 37), 'text':'that regulate both morphological and transcriptional responses'}]}, {'start':(46, 38), 'end':(46, 48), 'text':'to be coordinated during differentiation from a site in the cell'}]}, {'start':(46, 49), 'end':(46, 53), 'text':'that must undergo dramatic changes'}]}, {'start':(46, 54), 'end':(46, 57), 'text':'as myoblasts elongate ,'}]}]}, {'start':(46, 58), 'end':(46, 59), 'text':'align ,'}]}, {'start':(46, 60), 'end':(46, 63), 'text':'and ultimately fuse .'}]}]}]}]}, {'start':(47, 0), 'end':(47, 23), 'text':'Complete identification of the components and dynamics of such complexes should provide important insights into myogenesis in particular and cell differentiation in general .'}]}
40	146	{'label':'topic-change', 'direction':'None', 'children':[{'label':'topic-change', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 5), 'text':'Expression of netrins and netrin receptors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 6), 'end':(1, 8), 'text':'in cultured myoblasts'}, {'start':(2, 0), 'end':(2, 24), 'text':'Our interest in Ig and FNIII repeat proteins led us to examine expression of netrin receptors of this class during myogenic differentiation in vitro .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 13), 'text':'Western blot analyses of C2C12 myoblasts revealed a uniform level of neogenin in cells'}, {'start':(3, 14), 'end':(3, 17), 'text':'cultured in growth medium'}]}, {'start':(3, 18), 'end':(3, 22), 'text':'( GM ) and cells'}]}, {'start':(3, 23), 'end':(3, 35), 'text':'transferred into DM over a period of 4 d ( A ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 6), 'text':'This contrasts with expression of CDO ,'}, {'start':(4, 7), 'end':(4, 21), 'text':'which was transiently up regulated during the differentiation time course ( A ; ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 1), 'text':'Duplicate blots'}, {'start':(5, 2), 'end':(5, 19), 'text':'probed with an antibody against DCC revealed only trace levels of this protein ( unpublished data ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 4), 'text':'F3 , a myoblast line'}, {'start':(6, 5), 'end':(6, 15), 'text':'derived by treatment of 10T1 and 2 fibroblasts with 5-azacytidine ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 16), 'end':(6, 24), 'text':'also expressed neogenin under both GM and DM conditions'}, {'start':(6, 25), 'end':(6, 28), 'text':'( B ) .'}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 16), 'text':'10T1 and 2 fibroblasts and 10T1 and 2 cells converted to myoblasts by stable expression of MyoD'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 17), 'end':(7, 21), 'text':'expressed indistinguishable levels of neogenin'}, {'start':(7, 22), 'end':(7, 25), 'text':'( C ) ;'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 26), 'end':(7, 33), 'text':'again , this contrasts with CDO expression ,'}, {'start':(7, 34), 'end':(7, 43), 'text':'which was induced by MyoD ( C ; ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 9), 'text':'Finally , expression of oncogenic Ras in C2C12 cells ,'}, {'start':(8, 10), 'end':(8, 17), 'text':'which results in reduction of MyoD and CDO'}]}, {'start':(8, 18), 'end':(8, 34), 'text':'and blocks differentiation ( ) , had no effect on neogenin levels ( unpublished data ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'Together , these results indicate'}, {'start':(9, 5), 'end':(9, 13), 'text':'that neogenin is expressed in the myogenic lineage ,'}]}, {'start':(9, 14), 'end':(9, 23), 'text':'but its expression is not dependent on myogenic factors .'}]}, {'start':(10, 0), 'end':(10, 8), 'text':'Specific netrins were examined in a similar fashion .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 14), 'text':'Netrin-3 was expressed in both C2C12 and F3 cells under GM conditions and levels increased'}, {'start':(11, 15), 'end':(11, 23), 'text':'when cells were transferred into DM ( ) .'}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 12), 'text':'This increase was also apparent at the mRNA level , with C2C12 cells'}, {'start':(12, 13), 'end':(12, 25), 'text':'displaying a single netrin-3 transcript of ~ 7 kb ( D ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 24), 'text':'In contrast , duplicate Western and Northern blots probed for expression of netrin-1 protein and mRNA , respectively , did not reveal a signal ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 25), 'end':(13, 27), 'text':'despite the ability'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 28), 'end':(13, 30), 'text':'to detect netrin-1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 31), 'end':(13, 32), 'text':'produced transiently'}, {'start':(13, 33), 'end':(13, 37), 'text':'( unpublished data ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 0), 'text':'Netrin-3'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 1), 'end':(14, 17), 'text':'produced by C2C12 cells was not observed in the culture medium supernatant ( unpublished data ) ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(14, 18), 'end':(14, 18), 'text':'suggesting'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(14, 19), 'end':(14, 37), 'text':'that , like endogenous netrins-1 and -2 in chick floor plate and netrin-1 in adult rat spinal cord ,'}, {'start':(14, 38), 'end':(14, 51), 'text':'it is likely to be associated with cell membranes and and or ECM .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 10), 'text':'10T1 and 2 and 10T1 and 2-MyoD cells also expressed netrin-3'}, {'start':(15, 11), 'end':(15, 14), 'text':'( C ) .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 2), 'text':'It is concluded'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 3), 'end':(16, 22), 'text':'that myoblast cell lines and 10T1 and 2 cells express both netrin-3 and one of its receptors , neogenin ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 23), 'end':(16, 25), 'text':'raising the possibility'}, {'start':(16, 26), 'end':(16, 36), 'text':'that an autocrine signaling pathway may exist in these cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 4), 'text':'Neogenin levels regulate myotube formation'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(18, 0), 'end':(18, 8), 'text':'To assess a role for neogenin in myogenesis ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 9), 'end':(18, 23), 'text':'we transfected different " strains " of C2C12 cells and F3 cells with a vector'}, {'start':(18, 24), 'end':(18, 38), 'text':'engineered to drive expression of a human neogenin cDNA and a puromycin resistance gene .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 3), 'text':'Transfected cultures were selected'}, {'start':(19, 4), 'end':(19, 9), 'text':'and analyzed for neogenin expression .'}]}]}, {'start':(20, 0), 'end':(20, 13), 'text':'Stable overexpression of neogenin was achieved only in one strain of C2C12 cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 2), 'text':'These cells ,'}, {'start':(21, 3), 'end':(21, 6), 'text':'previously described by us'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 7), 'end':(21, 10), 'text':'and designated as C2C12'}, {'start':(21, 11), 'end':(21, 17), 'text':'( E ) cells ( ) ,'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(21, 18), 'end':(21, 20), 'text':'are highly differentiation-proficient'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 21), 'end':(21, 24), 'text':'in that they :'}, {'start':(21, 25), 'end':(21, 33), 'text':'expressed detectable myogenin before a shift into DM ;'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 34), 'end':(21, 48), 'text':'( b ) were less sensitive to inhibition of differentiation by moderate levels of serum'}, {'start':(21, 49), 'end':(21, 56), 'text':'( e.g. , 5 % FBS ) ;'}]}]}, {'start':(21, 57), 'end':(21, 70), 'text':'and ( c ) completed the differentiation process over a 2-d time period .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(22, 0), 'end':(22, 7), 'text':'These cells were used for all subsequent experiments'}, {'start':(22, 8), 'end':(22, 16), 'text':'and are simply referred to as C2C12 cells .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 8), 'text':'Neogenin vector transfectants ( C2C12 and neogenin cells )'}, {'start':(23, 9), 'end':(23, 24), 'text':'produced two- to threefold more neogenin than control vector transfectants ( C2C12 and puro cells ;'}]}, {'start':(23, 25), 'end':(23, 27), 'text':'A ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(24, 0), 'end':(24, 16), 'text':'Overproduction of neogenin modestly decreased proliferation of C2C12 cells in GM , relative to vector controls ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 17), 'end':(24, 24), 'text':'and did not alter their morphology in GM'}, {'start':(24, 25), 'end':(24, 29), 'text':'( not depicted ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 3), 'text':'When observed 24 h'}, {'start':(25, 4), 'end':(25, 9), 'text':'after shifting the cultures to medium'}]}, {'start':(25, 10), 'end':(25, 13), 'text':'containing 5 % FBS'}]}, {'start':(25, 14), 'end':(25, 16), 'text':'( a time'}]}, {'start':(25, 17), 'end':(25, 26), 'text':'at which the differentiation process was in mid-progression ) ,'}]}, {'start':(25, 27), 'end':(25, 47), 'text':'C2C12 and neogenin cells had formed larger myotubes with more nuclei than did C2C12 and puro cells ( B ) .'}]}, {'start':(26, 0), 'end':(26, 36), 'text':'C2C12 and neogenin cultures displayed an increase in the total number of nuclei present in myosin heavy chain ( MHC ) - positive cells and in the average number of nuclei and myotube ( C ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 8), 'text':'When analyzed for expression of muscle specific proteins ,'}, {'start':(27, 9), 'end':(27, 22), 'text':'including MyoD , myogenin , MHC , and troponin T ( TnT ) ,'}]}, {'start':(27, 23), 'end':(27, 32), 'text':'C2C12 and neogenin cells showed accelerated expression of TnT ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 33), 'end':(27, 41), 'text':'but otherwise were similar to C2C12 and puro cells'}, {'start':(27, 42), 'end':(27, 45), 'text':'( D ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 19), 'text':'Overexpression of neogenin therefore resulted in enhanced formation of myotubes without dramatic changes in several biochemical markers of differentiation .'}, {'start':(29, 0), 'end':(29, 17), 'text':'To assess the effect of reducing neogenin levels on myotube formation , an RNAi approach was taken .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 14), 'text':'A sequence from the mouse neogenin coding region was inserted into the pSilencer vector ,'}, {'start':(30, 15), 'end':(30, 26), 'text':'and was cotransfected with a GFP expression vector into C2C12 cells ;'}]}, {'start':(30, 27), 'end':(30, 38), 'text':'the pSilencer vector without an insert was used as a control .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(31, 0), 'end':(31, 8), 'text':'Transfected cultures were sorted for the presence of GFP'}, {'start':(31, 9), 'end':(31, 16), 'text':'and assessed for reduction of neogenin levels .'}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 10), 'text':'A representative Western blot is shown in A. GFP sorted cells'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(32, 11), 'end':(32, 21), 'text':'that received the neogenin RNAi vector produced fewer and smaller myotubes'}, {'start':(32, 22), 'end':(32, 26), 'text':'than sorted control transfectants .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(33, 0), 'end':(33, 6), 'text':'To more precisely quantify this effect ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 7), 'end':(33, 18), 'text':'C2C12 cells were cotransfected with the neogenin RNAi vector or the vector'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 19), 'end':(33, 29), 'text':'lacking an insert , plus a plasmid directing expression of nlacZ'}, {'start':(33, 30), 'end':(33, 35), 'text':'( encoding nuclear localized beta-galactosidase ;'}]}]}, {'start':(33, 36), 'end':(33, 38), 'text':'beta-gal ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(34, 0), 'end':(34, 15), 'text':'2 d later , the cultures were transferred to 5 % FBS for 24 h ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(34, 16), 'end':(34, 18), 'text':'and then fixed'}, {'start':(34, 19), 'end':(34, 27), 'text':'and double stained for MHC and beta-gal activity .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 7), 'text':'When control vector-transfectants fused with nontransfected cells ,'}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(35, 8), 'end':(35, 24), 'text':'many ( often most ) of the nuclei in the myotube became positive for beta-gal activity ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 25), 'end':(35, 30), 'text':'presumably because the cytoplasmically translated protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 31), 'end':(35, 34), 'text':'diffused within the myotube'}, {'start':(35, 35), 'end':(35, 38), 'text':'( B ) .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(36, 0), 'end':(36, 11), 'text':'When the number of nuclei in beta-gal + cells was scored ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(36, 12), 'end':(36, 20), 'text':'~ 56 % had more than five nuclei ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(36, 21), 'end':(36, 28), 'text':'~ 21 % had two to four nuclei'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 29), 'end':(36, 36), 'text':'and ~ 23 % had a single nucleus'}, {'start':(36, 37), 'end':(36, 40), 'text':'( C ) .'}]}]}]}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 8), 'text':'In contrast , the distribution of beta-gal + cells'}, {'start':(37, 9), 'end':(37, 20), 'text':'that received the neogenin RNAi vector was strongly skewed toward single nucleus'}]}, {'start':(37, 21), 'end':(37, 23), 'text':'containing cells ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 24), 'end':(37, 34), 'text':'with only about ~ 5 % displaying more than five nuclei'}, {'start':(37, 35), 'end':(37, 38), 'text':'( C ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 0), 'text':'Cells'}, {'start':(38, 1), 'end':(38, 5), 'text':'that received an RNAi vector'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 6), 'end':(38, 9), 'text':'containing a neogenin sequence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 10), 'end':(38, 21), 'text':'that was ineffective at reducing neogenin protein levels behaved equivalently to those'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 22), 'end':(38, 25), 'text':'that received the vector'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 26), 'end':(38, 28), 'text':'lacking an insert'}, {'start':(38, 29), 'end':(38, 33), 'text':'( unpublished data ) .'}]}]}]}]}]}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 14), 'text':'As a further test of specificity , we sought to rescue the cell fusion defect'}, {'start':(39, 15), 'end':(39, 27), 'text':'produced by neogenin RNAi via ectopic expression of the human neogenin cDNA .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 19), 'text':'The sequence of the RNAi used to target endogenous mouse neogenin is not fully conserved in the human cDNA ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 20), 'end':(40, 31), 'text':'and therefore the human neogenin expression vector should be impervious to RNAi'}, {'start':(40, 32), 'end':(40, 36), 'text':'mediated " knockdown " .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 4), 'text':'Three conditions were studied :'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 5), 'end':(41, 9), 'text':'( 1 ) C2C12 cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 10), 'end':(41, 23), 'text':'cotransfected with pSilencer lacking RNAi sequences and the control vector for human neogenin expression'}, {'start':(41, 24), 'end':(41, 29), 'text':'( pSil and pBP ) ;'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 30), 'end':(41, 33), 'text':'( 2 ) cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 34), 'end':(41, 36), 'text':'cotransfected with pSilencer'}, {'start':(41, 37), 'end':(41, 54), 'text':'containing neogenin RNAi sequences and the control vector for human neogenin expression ( RNAi and pBP ) ;'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 55), 'end':(41, 59), 'text':'and ( 3 ) cells'}, {'start':(41, 60), 'end':(41, 77), 'text':'cotransfected with pSilencer containing RNAi sequences and the human neogenin expression vector ( RNAi and hNeogenin ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 19), 'text':'For unknown reasons , the pSil and pBP transfectants reproducibly produced fewer myotubes with more than five nuclei than cells'}, {'start':(42, 20), 'end':(42, 42), 'text':'that received only the control pSilencer vector ( ~ 30 % vs. ~ 56 % , respectively ; compare D with ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 14), 'text':'Importantly , however , RNAi and pBP transfectants were strongly blocked from forming myotubes ,'}, {'start':(43, 15), 'end':(43, 31), 'text':'whereas the RNAi and hNeogenin transfectants closely resembled the control pSil and pBP cultures ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 15), 'text':'Therefore , forced expression of neogenin rescued the effects of RNAi to neogenin , further indicating'}, {'start':(44, 16), 'end':(44, 24), 'text':'that the effects of the RNAi were specific .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 0), 'end':(45, 2), 'text':'It is concluded'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 3), 'end':(45, 11), 'text':'that reduction of neogenin levels reduced myoblasts \' ability'}, {'start':(45, 12), 'end':(45, 19), 'text':'to participate in the formation of myotubes .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(46, 0), 'end':(46, 7), 'text':'Together , with the overexpression data in ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 8), 'end':(46, 11), 'text':'these results strongly suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 12), 'end':(46, 16), 'text':'that neogenin levels are rate'}, {'start':(46, 17), 'end':(46, 24), 'text':'limiting for this aspect of C2C12 myogenesis .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 4), 'text':'Recombinant netrin promotes myotube formation'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 10), 'text':'To assess the effects of netrin-3 on myoblast cell lines ,'}, {'start':(48, 11), 'end':(48, 25), 'text':'we initially attempted to synthesize recombinant mouse protein in COS and 293T cells but ,'}]}, {'start':(48, 26), 'end':(48, 31), 'text':'similar to the findings of ,'}]}, {'start':(48, 32), 'end':(48, 40), 'text':'were unable to produce sufficient quantities of secreted ,'}]}, {'start':(48, 41), 'end':(48, 43), 'text':'soluble material .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 6), 'text':'Mouse netrin-3 is orthologous to human netrin-2L'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(49, 7), 'end':(49, 8), 'text':'and ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(49, 9), 'end':(49, 15), 'text':'although not orthologous to chicken netrin-2 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 16), 'end':(49, 27), 'text':'is grouped with both these proteins by dendrogram analyses in a sub-category'}, {'start':(49, 28), 'end':(49, 42), 'text':'designated " netrin-2-like " , distinguishable from a " netrin-1-like " group ( ) .'}]}]}]}]}]}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 11), 'text':'Therefore , we chose to use recombinant chicken netrin-2 for this work'}, {'start':(50, 12), 'end':(50, 17), 'text':'as it is commercially available .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 6), 'text':'C2C12 cells were cultured in GM ,'}, {'start':(51, 7), 'end':(51, 18), 'text':'then transferred into 5 % FBS plus or minus chicken netrin-2 ,'}]}, {'start':(51, 19), 'end':(51, 24), 'text':'and observed 24 h later .'}]}, {'start':(52, 0), 'end':(52, 9), 'text':'C2C12 cell proliferation was not altered by netrin-2 treatment .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(53, 0), 'end':(53, 1), 'text':'However ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(53, 2), 'end':(53, 14), 'text':'although the control cultures displayed small MHC + myotubes under these conditions ,'}, {'start':(53, 15), 'end':(53, 45), 'text':'the netrin-2-treated cultures showed distinctly larger myotubes with increases in the total number of nuclei in MHC + cells and in the average number of nuclei and myotube ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(54, 0), 'end':(54, 8), 'text':'When analyzed for expression of muscle specific proteins ,'}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 9), 'end':(54, 10), 'text':'the cells'}, {'start':(54, 11), 'end':(54, 21), 'text':'that received netrin-2 produced significantly more TnT than control cells ,'}]}, {'start':(54, 22), 'end':(54, 39), 'text':'but the levels of MyoD , myogenin , MHC , and CDO were unchanged ( C ) .'}]}]}, {'start':(55, 0), 'end':(55, 34), 'text':'Thus , similar to overexpression of neogenin , treatment of C2C12 cells with a neogenin ligand resulted in enhanced myotube formation and alterations in expression of TnT , but not several other muscle markers .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(56, 0), 'end':(56, 1), 'text':'To assess'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 2), 'end':(56, 20), 'text':'whether netrin-2 exerted its effects on myotube formation in a manner dependent on neogenin , a C2C12 cell derivative'}, {'start':(56, 21), 'end':(56, 30), 'text':'that stably expressed the neogenin RNAi vector was generated ;'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(56, 31), 'end':(56, 39), 'text':'these cells expressed considerably less neogenin than control transfectants'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(56, 40), 'end':(56, 48), 'text':'and produced fewer and smaller myotubes than control transfectants'}, {'start':(56, 49), 'end':(56, 64), 'text':'when shifted to DME and 5 % FBS for 24 h ( , A-C ) .'}]}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(57, 0), 'end':(57, 10), 'text':'When the control cells were treated with netrin-2 under these conditions'}, {'start':(57, 11), 'end':(57, 18), 'text':'they behaved similarly to parental C2C12 cells ,'}]}, {'start':(57, 19), 'end':(57, 25), 'text':'forming larger myotubes with more nuclei .'}]}, {'start':(58, 0), 'end':(58, 15), 'text':'In contrast , the neogenin RNAi expressing cells were not affected by netrin-2 ( ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(59, 0), 'end':(59, 4), 'text':'Therefore , it is concluded'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 5), 'end':(59, 9), 'text':'that the ability of netrin-2'}, {'start':(59, 10), 'end':(59, 24), 'text':'to promote myotube formation by C2C12 cells depends on the netrin receptor , neogenin .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 9), 'text':'Neogenin activates myogenic bHLH factor- and NFAT dependent reporter constructs'}, {'label':'joint', 'direction':'None', 'children':[{'start':(61, 0), 'end':(61, 11), 'text':'CDO signals to enhance myogenic bHLH factor dependent transcription ( ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(61, 12), 'end':(61, 16), 'text':'and netrin-1 signals through DCC'}, {'start':(61, 17), 'end':(61, 24), 'text':'to stimulate NFAT mediated transcription ( ) .'}]}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(62, 0), 'end':(62, 3), 'text':'Therefore , we assessed'}, {'start':(62, 4), 'end':(62, 17), 'text':'whether neogenin could stimulate reporter constructs specific for myogenic bHLH factors and NFAT .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 18), 'text':'In transient assays of C2C12 cells , cotransfection of the neogenin expression vector enhanced activity of a reporter construct'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 19), 'end':(63, 32), 'text':'driven by four reiterated myogenic E-boxes ( 4Rtk-luc ) , approximately threefold above that'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(63, 33), 'end':(63, 37), 'text':'seen with a control vector'}, {'start':(63, 38), 'end':(63, 45), 'text':'lacking a cDNA insert ( A ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(64, 0), 'end':(64, 21), 'text':'Cotransfection of 10T1 and 2 fibroblasts with expression vectors for MyoD and its heterodimeric partner E12 led to activation of 4Rtk-luc ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 22), 'end':(64, 33), 'text':'and this activity was also enhanced approximately threefold by coexpression of neogenin'}, {'start':(64, 34), 'end':(64, 37), 'text':'( B ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 0), 'end':(65, 17), 'text':'However , neogenin could not activate the reporter in the absence of MyoD ( unpublished data ) .'}, {'start':(66, 0), 'end':(66, 37), 'text':'Cotransfection of the neogenin expression vector into either C2C12 or 10T1 and 2 cells enhanced NFAT-luciferase reporter activity approximately twofold ; in contrast , a CDO expression vector had no effect on NFAT dependent transcription ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(67, 0), 'end':(67, 4), 'text':'Of the various NFATc isoforms'}, {'start':(67, 5), 'end':(67, 8), 'text':'implicated in myogenesis ,'}]}, {'start':(67, 9), 'end':(67, 19), 'text':'only NFATc3 is activated in differentiating C2C12 myoblasts ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 0), 'end':(68, 26), 'text':'To assess whether netrin-neogenin signaling could activate NFATc3 , C2C12 and 10T1 and 2 cells were treated with recombinant chicken netrin-2 for 6 or 30 h. Immunoblots'}, {'start':(68, 27), 'end':(68, 45), 'text':'probed with an antibody specific to NFATc3 revealed increased levels of NFATc3 after 6 h of netrin-2 treatment ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 46), 'end':(68, 48), 'text':'including a more'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(68, 49), 'end':(68, 51), 'text':'quickly migrating form'}, {'start':(68, 52), 'end':(68, 56), 'text':'that presumably represents dephosphorylated ,'}]}, {'start':(68, 57), 'end':(68, 62), 'text':'activated NFATc3 ( E ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 23), 'text':'This response returned to baseline , or lower , within 30 h. Consistent with this relatively short duration of action , addition of netrin-2'}, {'start':(69, 24), 'end':(69, 27), 'text':'to control or neogenin'}]}, {'start':(69, 28), 'end':(69, 46), 'text':'transfected cultures enhanced NFAT-luciferase reporter activity by only ~ 40 % in each case ( unpublished data ) .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(70, 0), 'end':(70, 13), 'text':'To assess whether the effects of netrin-2 on NFATc3 were dependent on neogenin ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(70, 14), 'end':(70, 32), 'text':'C2C12 cells were transiently transfected with neogenin RNAi or control vectors plus a GFP expression vector , sorted ,'}, {'start':(70, 33), 'end':(70, 46), 'text':'and treated with medium containing 5 % FBS , plus or minus netrin-2 .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 17), 'text':'Netrin-2 treatment of control transfectants resulted in increased levels of NFATc3 , similar to parental C2C12 cells ;'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 18), 'end':(71, 28), 'text':'in contrast , neogenin RNAi transfectants failed to respond to netrin-2'}, {'start':(71, 29), 'end':(71, 32), 'text':'( F ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 0), 'end':(72, 2), 'text':'The C2C12 derivative'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(72, 3), 'end':(72, 15), 'text':'that stably expressed neogenin RNAi ( ) displayed a similar lack of response'}, {'start':(72, 16), 'end':(72, 19), 'text':'( G ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(73, 0), 'end':(73, 1), 'text':'Thus ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(73, 2), 'end':(73, 9), 'text':'as seen with enhancement of myotube formation ,'}, {'start':(73, 10), 'end':(73, 20), 'text':'netrin-2 required neogenin to exert its effects on NFATc3 levels .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 0), 'end':(74, 5), 'text':'Neogenin forms a complex with CDO'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 0), 'end':(75, 15), 'text':'Ig and FNIII proteins can bind in a cis fashion to additional members of this family'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 16), 'end':(75, 18), 'text':'to form complexes'}, {'start':(75, 19), 'end':(75, 23), 'text':'that regulate their function .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(76, 0), 'end':(76, 14), 'text':'For example , Robo receptors bind to DCC to silence netrin-1-mediated attraction ( ) ,'}, {'start':(76, 15), 'end':(76, 24), 'text':'and BOC binds CDO to stimulate myogenesis ( ) .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(77, 0), 'end':(77, 9), 'text':'To test whether neogenin might also interact with CDO ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(77, 10), 'end':(77, 23), 'text':'lysates from C2C12 and F3 cells were immunoprecipitated with antibodies to CDO or neogenin'}, {'start':(77, 24), 'end':(77, 30), 'text':'and blotted with the reciprocal antibody .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(78, 0), 'end':(78, 17), 'text':'Neogenin was present in CDO immunoprecipitates , and CDO in neogenin immunoprecipitates , from both cell lines ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(78, 18), 'end':(78, 18), 'text':'suggesting'}, {'start':(78, 19), 'end':(78, 30), 'text':'that these two proteins do indeed form a complex ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(79, 0), 'end':(79, 10), 'text':'More neogenin co-immunoprecipitated with CDO under DM than GM conditions ,'}, {'start':(79, 11), 'end':(79, 26), 'text':'although this enhanced association in DM was not evident in the reciprocal co-immunoprecipitation ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(80, 0), 'end':(80, 7), 'text':'Co-immunoprecipitation of neogenin and CDO was not diminished'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(80, 8), 'end':(80, 21), 'text':'when C2C12 cells were collected as a single-cell suspension in the presence of EDTA'}, {'start':(80, 22), 'end':(80, 22), 'text':'('}]}, {'start':(80, 23), 'end':(80, 29), 'text':'which blocks cadherin mediated adhesion ) ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(80, 30), 'end':(80, 30), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(80, 31), 'end':(80, 38), 'text':'that the interaction occurs in a cis fashion'}, {'start':(80, 39), 'end':(80, 42), 'text':'( C ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(81, 0), 'end':(81, 10), 'text':'CDO associates with N- and M-cadherins in myoblasts ( ) ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 11), 'end':(81, 16), 'text':'and cadherins also co-immunoprecipitated with neogenin'}, {'start':(81, 17), 'end':(81, 20), 'text':'( B ) ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(81, 21), 'end':(81, 21), 'text':'suggesting'}, {'start':(81, 22), 'end':(81, 32), 'text':'these proteins may interact together in a higher order structure .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(82, 0), 'end':(82, 4), 'text':'Furthermore , consistent with netrin-3'}, {'start':(82, 5), 'end':(82, 13), 'text':'functioning as a neogenin ligand in C2C12 cells ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(82, 14), 'end':(82, 20), 'text':'it too was observed in neogenin immunoprecipitates'}, {'start':(82, 21), 'end':(82, 24), 'text':'( B ) .'}]}]}, {'start':(83, 0), 'end':(83, 19), 'text':'To investigate complex formation between CDO and neogenin in more detail , transient transfections in 293T cells were performed .'}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(84, 0), 'end':(84, 6), 'text':'Neogenin was brought down by CDO antibodies'}, {'label':'joint', 'direction':'None', 'children':[{'start':(84, 7), 'end':(84, 18), 'text':'when CDO was coexpressed , but not when CDO was omitted ;'}, {'start':(84, 19), 'end':(84, 35), 'text':'analogously , CDO was brought down by neogenin antibodies in a neogenin dependent fashion ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(85, 0), 'end':(85, 5), 'text':'As seen with C2C12 cells ,'}, {'start':(85, 6), 'end':(85, 30), 'text':'collection of transiently transfected 293T cells as a single-cell suspension in EDTA did not diminish the association between neogenin and CDO ( F ) .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(86, 0), 'end':(86, 1), 'text':'Additionally ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 2), 'end':(86, 4), 'text':'when 293T transfectants'}, {'start':(86, 5), 'end':(86, 12), 'text':'that expressed only CDO were cocultured with transfectants'}]}, {'start':(86, 13), 'end':(86, 17), 'text':'that expressed only neogenin ,'}]}, {'label':'condition', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 18), 'end':(86, 29), 'text':'immunoprecipitation of either protein failed to coprecipitate the other , an interaction'}, {'start':(86, 30), 'end':(86, 33), 'text':'expected to be observed'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 34), 'end':(86, 41), 'text':'if the binding occurred in a trans manner'}, {'start':(86, 42), 'end':(86, 46), 'text':'( unpublished data ) .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'textual-organization', 'direction':'None', 'children':[{'start':(87, 0), 'end':(87, 6), 'text':'Together , the transient expression data :'}, {'label':'joint', 'direction':'None', 'children':[{'start':(87, 7), 'end':(87, 13), 'text':'establish the specificity of the antibodies ;'}, {'label':'joint', 'direction':'None', 'children':[{'start':(87, 14), 'end':(87, 25), 'text':'( b ) confirm the cis nature of the CDO-neogenin association ;'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(87, 26), 'end':(87, 30), 'text':'and ( c ) indicate'}, {'start':(87, 31), 'end':(87, 47), 'text':'that additional , cell type specific factors are not likely to be required for this interaction .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(88, 0), 'end':(88, 3), 'text':'CDO contains an ectodomain'}, {'start':(88, 4), 'end':(88, 27), 'text':'comprised of five Ig and three FNIII repeats , a single pass transmembrane region , and a 270-amino acid cytoplasmic tail ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(89, 0), 'end':(89, 4), 'text':'To identify regions of CDO'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 5), 'end':(89, 17), 'text':'involved in complex formation with neogenin , a series of CDO deletion mutants'}, {'start':(89, 18), 'end':(89, 34), 'text':'that lack each individual Ig and FNIII repeat were tested for their ability to co-immunoprecipitate neogenin .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(90, 0), 'end':(90, 17), 'text':'293T cells were transiently transfected with expression vectors for neogenin and either wild-type CDO or individual CDO mutants'}, {'start':(90, 18), 'end':(90, 32), 'text':'( designated by the symbol " Delta " followed by the deleted domain ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(91, 0), 'end':(91, 11), 'text':'Cell lysates were precipitated with antibodies to the CDO intracellular region ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(91, 12), 'end':(91, 15), 'text':'and the immunoprecipitates blotted'}, {'start':(91, 16), 'end':(91, 27), 'text':'and probed with antibodies to neogenin or CDO ( G ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(92, 0), 'end':(92, 16), 'text':'The CDO mutants DeltaIg1 and DeltaFN2 were deficient ( though not completely defective ) in their ability'}, {'start':(92, 17), 'end':(92, 26), 'text':'to associate with neogenin , relative to full-length CDO .'}]}, {'start':(93, 0), 'end':(93, 18), 'text':'In contrast , DeltaIg2 , DeltaIg4 , DeltaIg5 , and DeltaFN1 displayed no significant reduction in this property .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(94, 0), 'end':(94, 8), 'text':'DeltaFN3 gave somewhat variable results over multiple experiments ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(94, 9), 'end':(94, 9), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(94, 10), 'end':(94, 16), 'text':'it may be involved in neogenin binding'}, {'start':(94, 17), 'end':(94, 26), 'text':'but is not as important as Ig1 or FN2 .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(95, 0), 'end':(95, 11), 'text':'Deletion of Ig repeat 3 apparently resulted in destabilization of CDO ,'}, {'start':(95, 12), 'end':(95, 22), 'text':'as only very weak expression of this protein was observed .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(96, 0), 'end':(96, 1), 'text':'A construct'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(96, 2), 'end':(96, 16), 'text':'in which the CDO signal sequence was linked directly to its transmembrane and cytoplasmic regions'}, {'start':(96, 17), 'end':(96, 23), 'text':'( designated CDO ( TMintra ) ;'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(96, 24), 'end':(96, 39), 'text':'Kang et al. , 2002 ) was brought down in neogenin immunoprecipitates , albeit inefficiently ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(96, 40), 'end':(96, 40), 'text':'suggesting'}, {'start':(96, 41), 'end':(96, 56), 'text':'that the intracellular regions of CDO and neogenin may also associate ( unpublished data ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(97, 0), 'end':(97, 9), 'text':'Together , the results in are consistent with the conclusion'}, {'label':'joint', 'direction':'None', 'children':[{'start':(97, 10), 'end':(97, 17), 'text':'that neogenin and CDO form complexes in cis'}, {'start':(97, 18), 'end':(97, 34), 'text':'and that this interaction is dependent on the presence of specific repeats in the CDO ectodomain .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(98, 0), 'end':(98, 7), 'text':'Despite its sequence similarity to , and ability'}, {'start':(98, 8), 'end':(98, 23), 'text':'to interact with , neogenin , CDO seems not to be an independent netrin receptor ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(98, 24), 'end':(98, 36), 'text':'in that it was unable to bind a netrin-1-Fc fusion protein under conditions'}, {'start':(98, 37), 'end':(98, 40), 'text':'where neogenin did .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(99, 0), 'end':(99, 13), 'text':'Furthermore , BOC was also unable to bind netrin-1-Fc , and coexpression of CDO'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(99, 14), 'end':(99, 26), 'text':'and and or BOC did not appear to alter netrin-1-Fc binding to neogenin'}, {'start':(99, 27), 'end':(99, 31), 'text':'( unpublished data ) .'}]}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(100, 0), 'end':(100, 7), 'text':'To gain insight into whether neogenin \'s ability'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(100, 8), 'end':(100, 19), 'text':'to bind to CDO is important for netrin-neogenin signaling , primary myoblasts'}, {'start':(100, 20), 'end':(100, 42), 'text':'derived from wild-type mice and mice homozygous for a targeted mutation of Cdo were analyzed for their response to recombinant chicken netrin-2 .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(101, 0), 'end':(101, 1), 'text':'Cdo +'}, {'start':(101, 2), 'end':(101, 6), 'text':'/ + and Cdo -'}]}, {'start':(101, 7), 'end':(101, 7), 'text':'/'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(101, 8), 'end':(101, 15), 'text':'- myoblasts express similar levels of MyoD ,'}, {'start':(101, 16), 'end':(101, 21), 'text':'but during differentiation Cdo - /'}]}]}, {'start':(101, 22), 'end':(101, 36), 'text':'- cells produce lower levels of myogenin and form myotubes very inefficiently ( ) .'}]}]}, {'start':(102, 0), 'end':(102, 20), 'text':'Like myoblast cell lines , primary myoblasts expressed netrin-3 and neogenin , regardless of their Cdo genotype ( A ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(103, 0), 'end':(103, 12), 'text':'Before treatment with netrin-2 , Cdo + / + and Cdo - /'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(103, 13), 'end':(103, 37), 'text':'- myoblasts were similar in that each expressed somewhat higher levels of the more slowly migrating form of NFATc3 than the more quickly migrating ,'}, {'start':(103, 38), 'end':(103, 40), 'text':'presumably activated ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(103, 41), 'end':(103, 41), 'text':'form'}, {'start':(103, 42), 'end':(103, 45), 'text':'( B ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(104, 0), 'end':(104, 10), 'text':'After 3 h of exposure to netrin-2 , the Cdo +'}, {'start':(104, 11), 'end':(104, 24), 'text':'/ + cells showed a pronounced shift to the more quickly migrating form ,'}]}, {'start':(104, 25), 'end':(104, 31), 'text':'consistent with activation of NFAT signaling ;'}]}, {'start':(104, 32), 'end':(104, 38), 'text':'in contrast , the Cdo - /'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(104, 39), 'end':(104, 54), 'text':'- myoblasts showed no response and the ratio of the two forms of NFATc3 resembled that'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(104, 55), 'end':(104, 58), 'text':'seen in untreated cells'}, {'start':(104, 59), 'end':(104, 62), 'text':'( B ) .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(105, 0), 'end':(105, 21), 'text':'Therefore , loss of CDO resulted in loss of responsiveness to netrin-2 despite the presence of normal levels of its receptor ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(105, 22), 'end':(105, 22), 'text':'suggesting'}, {'start':(105, 23), 'end':(105, 36), 'text':'that neogenin \'s interaction with CDO is important for signaling by this pathway .'}]}]}]}]}
